3004.90.92.57 - Containing pantoprazole or its salts 🖩

This HTS classification, 3004.90.92.57, specifically identifies pharmaceutical preparations containing pantoprazole or its salts. These products are intended for therapeutic or prophylactic use, falling under the broader category of medicaments affecting the digestive system. Pantoprazole is a proton pump inhibitor (PPI) commonly used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome by reducing stomach acid production.

This subcategory is distinct from its sibling entries by its precise active ingredient. For instance, it differs from 3004.90.92.56, which covers medicaments containing famotidine, another type of acid-reducing medication (H2 blocker), and from 3004.90.92.50 (laxatives) and 3004.90.92.55 (antacids), which address different gastrointestinal ailments. The "Other" sibling categories encompass medicaments affecting the digestive system that do not contain pantoprazole, famotidine, are not laxatives, or antacids.

As this is a leaf node in the HTS structure, there are no further subcategories under 3004.90.92.57. Therefore, the classification hinges directly on the presence of pantoprazole or its salts within the medicament, when presented in measured doses or packings for retail sale, and specifically when primarily intended to affect the digestive system. Classification requires confirmation of pantoprazole as the principal active ingredient for the intended therapeutic purpose.